EVALUATION OF THE SERUM MELATONIN LEVELS IN THE TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALIMORADIAN ABBAS; SHAMSI MOHSEN; FARAJI FARDIN; AHMADI MEHDI; SAYYEDI SAYYED EBRAHIM

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ) Year:2018 | Volume:21 | Issue:2 (131) Page(s): 55-64

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

752

Download:

Cites:

Information Journal Paper

Title

EVALUATION OF THE SERUM MELATONIN LEVELS IN THE TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS

Author(s)

Keywords

MELATONINQ1

MULTIPLE SCLEROSISQ1

PATIENTSQ1

SERUM EVALUATIONQ1

Abstract

Background: MULTIPLE SCLEROSIS (MS) is a myelinating inflammation and an impairment of neuronal cell regeneration in the central nervous system with unknown causes. The aim of this study was to evaluate serum MELATONIN levels in the treatment of PATIENTS with MULTIPLE SCLEROSIS.Materials and Methods: A prospective study and a Cohort were conducted on 40 MS PATIENTS with MULTIPLE SCLEROSIS PATIENTS referring to instituate MS in Arak city for one year. In this study, PATIENTS who were treated with interferon-moderating drugs and who had not been treated for more than one year were randomly selected. A questionnaire containing demographic information and clinical information and separation of interacting factors was completed and completed. Clinical information included MRI, VEP, EDSS (Expanded Disability Status Scale) score, and clinical symptoms. The PATIENTS also received peripheral blood samplers 3 times in 6 months intervals to measure MELATONIN and their MELATONIN levels, and then the relationship between the data obtained from the patient's clinical data, EDSS, serum MELATONIN levels using the software SPSS with ANOVA and Post-hoc statistical analyzed.Results: In PATIENTS with MS, in spite of receiving drug treatment, the level of MELATONIN as an antioxidant decreased in second order sampling, which is consistent with the deterioration of the patient' s clinical condition (EDSS test), and this is not observed in the control group.Conclusion: According to the findings of this study, it can be argued that the level of MELATONIN is a measurable objective and measurable variable (with the help of ELISA) that can be used in the follow-up of these PATIENTS, along with clinical evaluations and questionnaires.

Cites

No record.

References

No record.

Cite

APA: Copy

ALIMORADIAN, ABBAS, SHAMSI, MOHSEN, FARAJI, FARDIN, AHMADI, MEHDI, & SAYYEDI, SAYYED EBRAHIM. (2018). EVALUATION OF THE SERUM MELATONIN LEVELS IN THE TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS. ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ), 21(2 (131) ), 55-64. SID. https://sid.ir/paper/69150/en

Vancouver: Copy

ALIMORADIAN ABBAS, SHAMSI MOHSEN, FARAJI FARDIN, AHMADI MEHDI, SAYYEDI SAYYED EBRAHIM. EVALUATION OF THE SERUM MELATONIN LEVELS IN THE TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS. ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ)[Internet]. 2018;21(2 (131) ):55-64. Available from: https://sid.ir/paper/69150/en

IEEE: Copy

ABBAS ALIMORADIAN, MOHSEN SHAMSI, FARDIN FARAJI, MEHDI AHMADI, and SAYYED EBRAHIM SAYYEDI, “EVALUATION OF THE SERUM MELATONIN LEVELS IN THE TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS,” ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ), vol. 21, no. 2 (131) , pp. 55–64, 2018, [Online]. Available: https://sid.ir/paper/69150/en

Related Journal Papers